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Abstract
Background—Improving predictive accuracy is of paramount importance for early detection
and prevention of psychosis. We sought a symptom severity classifier that would improve
psychosis risk prediction.
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Methods—Subjects were from two cohorts of the North American Prodrome Longitudinal
Study. All subjects met Criteria of Psychosis-Risk States. In Cohort-1 (n=296) we developed a
classifier that included those items of the Scale of Psychosis-Risk Symptoms that best
distinguished subjects who converted to psychosis from nonconverters, with performance initially
validated by randomization tests in Cohort-1. Cohort-2 (n=592) served as an independent test set.

Author Manuscript

Results—We derived 2-Item and 4-Item subscales. Both included unusual thought content and
suspiciousness; the latter added reduced ideational richness and difficulties with focus/
concentration. The Concordance Index (C-Index), a measure of discrimination, was similar for
each subscale across cohorts (4-Item subscale Cohort-2: 0.71, 95%CI=[0.64,0.77], Cohort-1: 0.74,
95%CI=[0.69,0.80]; 2-Item subscale Cohort-2: 0.68, 95%CI=[0.3,0.76], Cohort-1: 0.72,
95%CI=[0.66-0.79]). The 4-Item performed better than the 2-Item subscale in 742/1000 random
selections of 80% subsets of Cohort-2 subjects (p-value=1.3E-55). Subscale calibration between
cohorts was proportional (higher scores/lower survival), but absolute conversion risk predicted
from Cohort-1 was higher than that observed in Cohort-2, reflecting the cohorts’ differences in 2year conversion rates (Cohort-2: 0.16, 95%CI=[0.13,0.19]; Cohort-1: 0.30, 95%CI=[0.24,0.36]).
Conclusion—Severity of unusual thought content, suspiciousness, reduced ideational richness,
and difficulty with focus/concentration informed psychosis risk prediction. Scales based on these
symptoms may have utility in research and, assuming further validation, eventual clinical
applications.
Keywords
psychosis; high-risk; risk prediction; symptom severity; schizophrenia; survival
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Introduction
Development of preventative interventions for schizophrenia requires identifying persons at
very high risk. An early study examining psychosis conversion in persons meeting high-risk
diagnostic criteria reported a 45% 2-year conversion rate (Yung et al., 2004), however
subsequent studies found 2-year conversion rates that ranged from 15-30% (Demjaha et al.,
2012; DeVylder et al., 2014; Katsura et al., 2014; Lee et al., 2014; Liu et al.; Nelson et al.,
2013; Riecher-Rossler et al., 2009; Ruhrmann et al., 2010; Woods et al., 2009; Ziermans et
al., 2011). Efforts are needed to improve psychosis risk prediction.
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Prominent among the scales used to evaluate symptoms associated with psychosis risk is the
Scale of Psychosis-Risk Symptoms (SOPS) (McGlashan et al., 2010; Miller et al., 2002).
The SOPS comprises 19 symptoms in four domains that include: positive (unusual thought
content/delusional ideas, suspiciousness/persecutory ideas, grandiose ideas, perceptual
abnormalities/hallucinations, disorganized communication), negative (social anhedonia,
avolition, decreased expression of emotion, decreased experience of emotions and self,
reduced ideational richness, reduced occupational functioning), disorganized (odd behavior
or appearance, bizarre thinking, trouble with focus and attention, impaired hygiene), and
general (sleep disturbance, dysphoric mood, motor disturbances, impaired stress tolerance).
The symptoms evaluated by the SOPS were chosen to reflect broadly the symptoms
experienced by persons with schizophrenia during their prodrome.
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We sought to identify among items measured by the SOPS subsets that best predicted
psychosis conversion. We considered two large independent cohorts, the North American
Prodrome Longitudinal Study Cohort-1 and the North American Prodrome Longitudinal
Study Cohort-2. This allowed construction of risk prediction subscales in Cohort-1 and
evaluation of subscale performance in Cohort-2.

Methods
1_Subjects

Author Manuscript

Detailed study methods were reported previously (Addington et al., 2007; Addington et al.,
2012; Cannon et al., 2008). In brief, the North American Prodrome Longitudinal Study is a
multisite observational study of the predictors and mechanisms of conversion to psychosis in
persons meeting Criteria of Psychosis-Risk Syndromes (COPS) (Miller et al., 2003). There
were two non-overlapping waves of recruitment, Cohort-1 and Cohort-2. For Cohort-1 a
database combined the results post hoc from eight independent studies that used a
prospective design and similar ascertainment and rating methods (Addington et al., 2007).
Cohort-2 was developed as a 2-year prospective collaboration of the same eight sites
(Addington et al., 2012). For both cohorts, subjects’ ages ranged from 12 to 35. Studies were
approved by the sites’ Institutional Review Boards, and subjects provided written informed
consent or assent, with a parent/guardian consenting for persons under age 18.
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Study participants were evaluated using the Structured Interview for Psychosis-Risk
Syndromes (SIPS) (McGlashan et al., 2010; Miller et al., 2002) to determine if they met
criteria for one or more of the following high-risk syndromes: attenuated psychotic
symptoms syndrome; brief intermittent psychotic symptoms syndrome; and genetic risk and
deterioration syndrome. The Presence of Psychosis (POP) criteria (McGlashan et al., 2010;
Miller et al., 2002) were used to classify a subject as a “converter” to psychosis (see
Supplement for detailed criteria). For subjects who converted, date of conversion was
estimated by clinical interview and, if available, medical records. Diagnostic and Statistical
Manual IV (First, 2002) (DSM-IV) psychotic disorder diagnosis was based on Structured
Clinical Interview for DSM IV (First, 2002) performed by trained raters. Subjects were reassessed every six months by raters. While symptom severity was assessed at baseline, prior
to conversion, study raters had access to baseline ratings when evaluating conversion status.
There is a possibility that this knowledge could have impacted assessment of conversion. To
protect against possible bias all high-risk subjects were reviewed at study entry and at
conversion by experts (JA and TM) during a diagnostic conference call, to ensure that
criteria were met.
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The severity of symptoms was scored on the Scale of Psychosis-risk Symptoms (SOPS)
(McGlashan et al., 2010) as follows: 0 =absent; 1=questionably present; 2=mild;
3=moderate; 4=moderately severe; 5=severe but not psychotic; and 6=severe and psychotic.
To simplify analysis, we rescored mild and questionably present from “1” or “2” to “0”. We
rescored the threshold severity as follows: “moderate” as “1”; “moderately severe” as “2”;
“severe but not psychotic” as “3”; and “severe and psychotic” as “4”. Applying our analysis
strategy to the original scale had no effect on choice of informative symptoms.
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For Cohort-1, raters at each site were trained by the instrument’s developers and achieved
high inter-rater reliability for high-risk syndrome diagnoses (kappa >0.80) (Addington et al.,
2007; Cannon et al., 2008). In addition several sites participated in an evaluation of
symptom scoring reliability, achieving intra-class coefficients of > 0.7 for each item (Miller
et al., 2003). For Cohort-2, raters were required to have yearly assessments; intraclass
correlation coefficients for the SOPS total and positive subscales were required to be >0.8
(Addington et al., 2012).
We excluded from this report subjects who did not meet Criteria of Psychosis-Risk States,
who had no follow-up visits, or who had items missing from the baseline SOPS (Figure 1).
The follow-up period for survival analysis was two years (the duration of systematic followup for Cohort-2).
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2_Statistical Methods
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2.1 Classifier Development—We sought a “risk prediction subscale” for the SOPS,
meaning a sum of chosen items that best identified high-risk subjects who subsequently
developed psychosis. We used a simple “greedy algorithm” (Comen et al., 2009; Liu et al.,
2005) that first finds the best single item relative to a specified metric. Then, if possible, it
finds a second item that, when added to the first, most improves the metric, and so on. The
algorithm terminates when no additional items improve the metric. Classifier development
implemented the greedy algorithm using five-fold cross validation (Kohavi, 1995) with
Excel macros and add-ins (Moons et al., 2012). We excluded a random 25% of the subjects
from each group, then randomly partitioned the remaining subjects each into five nearly
equal subsets. Four converter and four nonconverter subsets were selected and the algorithm
applied to all of the 25 possible combinations of converter and nonconverter subsets. We
then randomly re-partitioned the five subsets and repeated the symptom selection process, a
total of 20 times, resulting in 500 trials. We then excluded a new random 25% of subjects,
and then repeated the entire process 10 times, thus generating 5000 total trials. As each
model was built ab initio from subsets of the data, the derived classifiers were not identical.
There is a wealth of literature on the merits of various model-building strategies (Hand,
2006; Harrell et al., 1984; Harrell et al., 1996; Kohavi, 1995) but less guidance on strategies
to best integrate the multiple derived classifiers. Our approach was to rank the symptoms by
their selection frequencies, with the most frequently selected items forming the integrated
classifiers.
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As part of the classifier development phase (Cohort-1) we used a randomization test (Fisher,
(1971) [1935]) to determine whether the derived subscales actually performed better than
chance. We did so because modern algorithms are capable of finding patterns even in
randomized data due to hidden interrelationships. The area under the curve (AUC) of the
receiver operating characteristic (ROC) is a plot of sensitivity (predicted positives/true
positives) and 1-specificity (predicted negatives/true negatives), at each possible cut-off
point for the scale score. From samples of real data, the typical AUC can be in excess of 0.5,
although 0.5 is the expected null value from random classification using prior probability
(Rucker et al., 2007). A randomization test requires that pseudo-classifiers are constructed
ab initio from pseudo-data with exactly the same algorithm used for true data (Buzkova et
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al., 2011; Lindgren et al., 1996; Rucker et al., 2007; Smit et al., 2008; Tropsha, 2010).
Applying this process 1000 times to Cohort-1 data, we created pseudo-data by randomly
assigning subjects to pseudo-groups of “converted” or “nonconverted,” preserving original
group sizes. Exactly the same classifier construction process as above was applied to the
pseudo-data to yield 1000 pseudo-classifiers.
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2.2 Survival Analysis—Validation was done with survival analyses using R version
3.1.2. We used two related measures to evaluate discrimination (Heagerty and Zheng, 2005).
To evaluate the ability of the prediction model to order the survival time we used the
Concordance Index (C-index) (Pencina and D'Agostino, 2004); and to order the survival
status (converter/nonconverter) the AUC (Blanche et al., 2013). Both the C-Index and the
AUC range from 0.5 (no predictive ability)-1.0 (perfect predictive ability). The success rate
difference (SRD) is the difference in conversion rates for subjects at high and low risk as
determined at a specified cut-off value for the scale, thus ranging from 0-1 (Kraemer and
Kupfer, 2006). As a measure of utility we used the Number Needed to Take (NNT)
(analagous to the more familiar “Number Needed to Treat”, a utility measure often used in
clinical trials); note that NNT=1/SRD (Kraemer and Kupfer, 2006). The NNT indicates how
many persons need to be identified as high-risk to detect one conversion more than that seen
in the low-risk group. The calibration plot, a scatterplot of the Kaplan-Meier survival
estimates at different classifier cutoff points, compares scaling of the classifiers in the two
cohorts.

Results
3.1 Study subjects (Table 1)
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Baseline evaluations for Cohort-1 occurred in 1998-2005 and for Cohort-2 in 2008-2013.
Compared to included subjects, excluded subjects had significantly lower parental education
in both cohorts. For Cohort-1, the diagnosis at conversion was known for 59 (66%): Bipolar
Disorder (n=6), Brief Psychotic Disorder (n=2), Delusional Disorder (n=2), Psychosis NOS
(n=16), Schizoaffective Disorder (n=6), Schizophrenia (n=15), and Schizophreniform
Disorder (n=12). For Cohort-2, the diagnosis at conversion was known for 78 (85%):
Bipolar Disorder (n=7), Brief Psychotic Disorder (n=2), Delusional Disorder (n=3),
Psychosis NOS (n=31), Schizoaffective Disorder (n=5), Schizophrenia (n=18), and
Schizophreniform Disorder (n=12).
3.2 Classifier development

Author Manuscript

The greedy algorithm was run repeatedly on randomly chosen subsets of converters and
nonconverters. With each run, somewhat different combinations of symptoms were chosen
(Figure 2). We observed greedy algorithm termination after choosing an average of 5.9
symptoms (of 19) (sd = 0.85). Suspiciousness/persecutory ideas (P2) and unusual thought
content (P1) and were chosen in almost all trials followed by reduced ideational richness
(N5) and trouble with focus and attention (D3). (See Supplement for detailed descriptions of
these symptoms.) Considering Figure 2, we defined a 2-Item subscale classifier as the sum
of the two most frequently selected symptoms (P1,P2) and a 4-Item subscale as the sum of
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the four most frequently selected symptoms (P1,P2,N5,D3). The same four were also first
selected when the greedy algorithm was applied to the full data.
3.3 Validation of Classifier Development Methods in Cohort-1
Computer-implemented classifier methods can find seemingly robust patterns in random
data, but the AUCs of random data should be low compared to the AUC of a classifier built
with true data. We applied exactly the same greedy algorithm to data where converter/
nonconverter group membership was randomly reassigned and calculated the resulting
AUC. The AUCs of each pseudo-classifier applied to its pseudo-data were summarized in a
histogram and fitted with a beta distribution (Figure 3). The AUC of the true 4-Item subscale
applied to Cohort-1 was 0.74 with a parametric p-value relative to the distribution of 3.9E-5.
Alternatively, since in exactly one of the 1000 trials, the pseudo-classifier AUC was by
chance better than the true AUC, a nonparametric p-value is (1+1)/(1000+1)=2.0E-3.
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3.4 Independent testing of classifier performance in Cohort-2
Cohort-2 baseline conversion rates at all time-points were less than those of Cohort-1
(Cannon et al., 2008; Woods et al., 2009)] (Figure 4).
In Cohort-2 discrimination, as evaluated with the C-Index, was consistently higher with the
4-Item than with the 2-Item subscale at all follow-up time points (Supplement, Figure S1).
At 2-years the C-Index for the 4-Item subscale was greater than the 2-Item subscale for 743
of 1000 trials of 80% (with replacement) randomly chosen subsets of subjects (pvalue=1.3E-55). In Cohort-2 at 2-years the 4-Item subscale was greater than the SOPS Total
in 968 of 1000 trials, and the 2-Item subscale greater than the SOPS Total in 883 of 1000
trials (p-values<1.3E-55).
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Using an optimized cut-off, the conversion rates over time were significantly higher for
persons declared “high-risk” compared to persons compared “low-risk” at times 6, 12, 18
and 24 months (Figure 4). The AUCs did not vary substantially over time.
Calibration curves compared scaling with a graph of the Kaplan-Meier survival (herein
nonconversion) proportions at 6, 12, 18, and 24 months, with values from Cohort-1
(predicted) on the x-axis and Cohort-2 (observed) on the y-axis (Figure 5). The Pearson R2
values, reported in the Figure legends for each time period, were all above 0.9, indicating
that higher subscale scores predicted lower survival proportionally in Cohort-1 and
Cohort-2. Miscalibration-in-the-large was apparent, however, related to the higher survival
rates seen in Cohort-2 relative to Cohort-1.
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Discussion
The performance of the 2-Item subscale indicates that the severity of unusual thought
content (P1), referential thinking (both P1,P2) and suspiciousness (P2) are key high-risk
symptoms. The majority of published studies examining symptoms and risk prediction
likewise have reported that items reflecting disordered thought content (unusual ideas
(Katsura et al., 2014; Nelson et al., 2013; Salokangas et al., 2013; Thompson et al., 2013;
Thompson et al., 2011; Wilcox et al., 2014), suspiciousness (Riecher-Rossler et al., 2009;
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Salokangas et al., 2013; Wilcox et al., 2014), bizarre thoughts (Ruhrmann et al., 2010), odd
beliefs/magical thinking (Mason et al., 2004), problems distinguishing fantasy and reality
(Klosterkotter et al., 2001), unstable ideas of reference (Klosterkotter et al., 2001),
derealization (Klosterkotter et al., 2001)) are more severe in converters than nonconverters;
this is despite variations in: diagnostic criteria for clinical high-risk; instruments to measure
symptom severity; and study populations (Schultze-Lutter et al., 2013) (Supplement, Table
S1). It is important to note that our reported performance of the subscales applied to persons
meeting Criteria of Psychosis-Risk States, and may be different in persons meeting other
high-risk diagnostic criteria.

Author Manuscript

Discrimination with the 4-Item subscale was, with certainty, better than that of the 2-Item
subscale; however, the magnitude of this difference was small, implying clinical importance
is yet to be determined. The 4-Item subscale (and the 2-Item subscale) also performed better
than the SOPS Total. However, we do not claim to have found optimal or unique
combinations of symptoms for psychosis risk prediction. Furthermore, there may be highrisk subtypes better predicted by different symptoms.
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There is further reason to continue to consider the two additional items in future studies. The
additional items reflect disturbances of thought process. N5 (reduced ideational richness) is
defined in the SOPS as having difficulties in: following everyday conversations; making
sense of familiar phrases; grasping the gist of conversations; escaping patterns of repetitious
or simplistic thought content; considering alternative positions; shifting ideas; using
anything but simplistic language; and thinking abstractly. D3 (trouble with focus and
attention) includes difficulties in: maintaining focused attention and resisting distraction due
to internal and external stimuli; holding conversations in memory; and executing other
short-term memory tasks. Other investigators have predicted psychosis risk from disordered
thought processes including: poor attention (Yung et al., 2004); disorganized cognitive
subscale (Demjaha et al., 2012); interference, perseveration, blockage, and pressure of
thoughts; disturbances of receptive language (Klosterkotter et al., 2001); and conceptual
disorganization (Nelson et al., 2013). Supporting the value of including disturbances in both
thought content and thought processes in defining the high-risk state is a recent study
(Schultze-Lutter et al., 2014) integrating the Criteria of Psychosis-Risk Syndromes (used in
this study) and COGDIS criteria, namely, meeting criteria for at least two of nine symptoms
from a list that includes “unstable ideas of reference” (partially overlapping with P1 and P2)
and eight symptoms reflecting disturbances of thought processes. Notably, the COGDIS
items “thought Interference” and “disturbance of receptive speech” partially overlap with
D3, and items “disturbances of abstract thinking” and “disturbance of receptive speech”
partially overlap with N5.
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It is notable that some symptoms were seldom or never selected (Figure 2). In particular, P4
(perceptual disturbances) is absent from our risk prediction subscales as it was infrequently
selected by the greedy algorithm. With two exceptions (Klosterkotter et al., 2001; Mason et
al., 2004), most other studies have likewise failed to find perceptual disturbances as
predictive (DeVylder et al., 2014; Katsura et al., 2014; Nelson et al., 2013; Riecher-Rossler
et al., 2009; Ruhrmann et al., 2010; Salokangas et al., 2013; Thompson et al., 2013;
Velthorst et al., 2009; Wilcox et al., 2014), including a factor-analysis where a factor
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including perceptual abnormalities, mood swings/lability, aggression/dangerous behaviors,
and suicidality/self-harm (symptoms common in personality disorders) was not predictive of
one-year conversion (Raballo et al., 2011). Psychosis high-risk diagnostic criteria
(Addington, 2004; Carpenter and Tandon, 2013), including those used in this study, would
classify a person with perceptual abnormalities alone as high-risk. These findings raise the
question of whether perceptual disturbances alone should be a diagnostic criteria for a
clinical high-risk syndrome.
As shown in Figure 3, we found that many models built using pseudo-data had AUCs above
0.6. Datasets with hidden relationships may show AUCs well above the hypothetical null
result 0.5 (Rucker et al., 2007). Randomization testing is a way to prove—to a certain pvalue— that the classifier performance in the test set is not unlikely by chance, thus
facilitating classifier development (Rucker et al., 2007; Tropsha, 2010).
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The 2-year conversion in Cohort-2 (16%) is at the low end of rates reported in recent studies
that range from 15-26% (Demjaha et al., 2012; DeVylder et al., 2014; Katsura et al., 2014;
Nelson et al., 2013; Ziermans et al., 2011). The calibration slope was similar in both cohorts,
meaning that, regardless of overall conversion rates, higher scores indicate proportionally
greater increase in psychosis risk. However calibration-in-the-large was dissimilar between
cohorts, reflecting in part the higher conversion rate in Cohort-1 than in Cohort-2. Case
identification strategies may influence the case-mix relative to psychosis risk; for example,
case identification through screenings of clinic or general populations may yield a broader
case-mix with lower conversion rates, possibly impacting calibration-in-the-large. The
emerging risk algorithms, biological or clinical, need to consider calibration before they are
used to provide absolute estimates of psychosis risk.
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In contemporary research settings, the 2-Item and 4-Item subscales might have utility in
identifying higher-risk subgroups in persons meeting Criteria of Psychosis-Risk Syndromes.
Considering Cohort-2; with the cutoffs presented in Figure 4d about a third of subjects met
the severity threshold with a 2-year conversion risk of 30% compared to 9% in the two-third
subjects identified as at lower risk. At 2-year follow-up, in Cohort-2 the NNT for the 2-Item
and 4-Item subscales were 5.3 and 4.8, respectively (corresponding to a medium effect size),
both lower than that of the SOPS Total (NNT=12.5), (corresponding to small effect size)
(Kraemer and Kupfer, 2006).
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Use of risk prediction subscales in clinical settings will require development of strategies to
educate community mental health care providers about assessment of high-risk symptoms
and diagnosis of a clinical high-risk state. In addition, discrimination and calibration of the
risk prediction subscales would need to be evaluated in the hands of trained community
providers prior to any recommendations about clinical usefulness (Salokangas et al., 2013).
In particular, calibration and discrimination may differ in community settings. About half of
persons diagnosed with psychotic disorders have sought mental health care prior to onset of
psychosis (Rietdijk et al., 2011), and as many as 4-8% of adolescents and young adults
seeking mental health care may meet clinical high-risk criteria (Ising et al., 2012; Rietdijk et
al., 2014); it is unclear whether these patient pools are fully represented in psychosis-risk
research. However, the potential value of symptom-based risk prediction to clinical practice
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is clear. That potential may be realized when scoring systems are developed that consider
the personal, social, and financial benefits of treatment (e.g. likelihood of psychosis
prevention) as well as costs (direct medical costs, side-effects, etc.) (Essock et al., 2002;
McNeil and Kaij, 1979). Applications of the present work might include treatment
monitoring, integration with other evaluations, and programs of stepwise application of
treatments, all in the context of prudent counseling (McGorry et al., 2009).

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

CONSORT Diagram of subjects included in Cohort-1 and Cohort-2.
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Figure 2.

Shown is the quartile plot reflecting the number of times each symptom was chosen for the
subscale (maximum was 500 times per run) over the 10 runs. Notably, the symptoms P2, P1,
N5, D3 dominated the choices, implying that all four are somewhat informative of transition
to psychosis. Other symptoms (e.g. N4) were seldom chosen as informative.
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Figure 3.
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Randomization test results of classifier development using data from Cohort-1 with group
(converter or nonconverter) randomly re-assigned, with AUC as metric. The histogram was
fitted accurately with a beta distribution (both Kolmogorov-Smirnov and Anderson-Darling
α > 0.01). The true classifier as derived with P2, P1, N5, D3 applied to the true data
achieved AUC = 0.74, having distribution p-value = 3.9E-5. Only once in 1000 trials did a
pseudo-classifier achieve a higher AUC, implying a nonparametric p-value = 0.002. Note
that, due to hidden interdependencies in the data, the pseudo-classifiers built with random
data frequently gave AUCs greater than 0.6, well above the customary and hypothetical
“random” AUC of 0.5.
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Figure 4.
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Kaplan Meier Survival Curves. For the 2-Item subscale, with a cutoff of 3, there were 80
(27%) Cohort-1 and 166 (28%) Cohort-2 subjects at “High Risk”. For the 4-Item subscale,
with a cutoff of 4, there were 98 (33%) Cohort-1 and 193 (33%) Cohort-2 subjects at “High
Risk”. Shadowed region indicates 95% confidence intervals. AUC (Area Under the Curve of
the Receiver Operating Characteristic) ranges from 0.5 to 1. The SRD (Success Rate
Difference) is the difference between survival in the high-risk and low-risk groups, and
ranges from 0-1. NNT (Number Needed to Take) indicates the number of persons that need
to be declared as high- and low-risk for one additional true converter to be detected in the
high-risk group. Black line indicates baseline, gold line indicates Low-Risk, and blue line
indicates High-Risk Kaplan-Meier (K-M) survival curves.
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Calibration curves comparing the observed performance in Cohort 2 with the predicted
performance of the 2-Item and 4-Item subscales from Cohort-1. Each point represents the
survival at particular time points (6, 12,18, & 24 months) at a specific cutoff point for the
subscales (observed scores for the 2-Item subscale ranged from 0-≥5, for the 4-Item subscale
ranged from 0-≥7). The blue diagonal line indicates perfect calibration. The Pearson
correlation of values from Cohort-1 and Cohort-2 at each time point is given in the legends.
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Demographic characteristics of included and excluded subjects in each cohort.
Cohort-1
Clinical High-Risk
Included
N=296

Cohort-1
Clinical High–Risk,
Excluded
N=81

Cohort-2
Clinical High-Risk
Included
N=592

Cohort-2
Clinical High–Risk,
Excluded
N=151

Mean

SD

Mean

SD

Mean

SD

Mean

SD

18.2

4.5

18.3

5.4

18.5

4.3

18.8

4.2

5.4

1.8

4.7

2.0

6.9

1.6

6.6

1.6

Scale of Psychosis-Risk
Symptoms Total

38.9

14.5

36.5

12.6

38.2

12.3

37.1

11.9

2-Item Subscale

2.5

1.7

2.6

1.9

2.6

1.6

2.6

1.6

4-Item Subscale

3.3

2.0

3.2

2.1

3.8

2.0

3.6

2.0

%

n

%

n

%

n

%

n

78.7%
-9.1%
4.7%
5.1%
2.3%

233
-27
14
15
7

75.3%
-8.6%
2.5%
8.6%
4.9%

61
-7
2
7
4

57.9%
4.1%
15.0%
7.3%
12.5%
3.2%

343
24
89
43
74
17

54.7%
6.0%
16.7%
6.7%
14.0%
1.7%

83
9
25
10
21
3

60%

178

72%

58

58%

54

53%

76

Age
1

Parental education

Author Manuscript

Ancestry,
Caucasian
Central/South America
African
Asian
Multiracial
Other
Sex, male

High risk syndrome (not mutually exclusive):
attenuated psychotic
symptoms

96%

284

94%

69

95%

562

94%

142

brief intermittent
psychotic symptoms

3%

9

6.2%

4

3%

18

1%

2

genetic risk and
functional deterioration

13%

38

12%

6

12%

71

9%

18
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1

In Cohort-1 included n=215 & excluded n=55; In Cohort-2 included n=585, excluded n=141, SES was significantly lower in persons with no
follow-up visits to those with at least one follow-up visit, Cohort 1 p-value= 0.02, Cohort-2 p-value=.05
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2.07

2.07
0.660.79

1.63,
2.62

95%
CI

0.68

2.14

value

0.63,
0.76

1.65,
2.78

95% CI

Cohort-2

0.74

3.09

value

0.69,
0.80

2.27,
4.21

95% CI

Cohort-1

0.71

2.99

value

0.64,
0.77

2.08,
4.29

95% CI

Cohort-2

4-Item Subscale

0.68

2.21

value

0.630.74

1.662.94

95% CI

Cohort-1

0.61

1.84

value

0.550.67

1.312.58

95%
CI

Cohort-2

Scale of Psychosis-Risk Symptoms
Total

At 2-years in Cohort 2 at 2-years in 80% randomly selected (with replacement) subject subsets the C-Index was higher for the 4-Item than for the 2-Item for 743 of 1000 trials, the C-Index was higher for
the 4-Item subscale than the SOPS Total for 968 of 1000 trials, and the C-Index was higher for the 2-Item subscale than the SOPS Total for 883 of 1000 trials, p-value<E-55.

2

To calculate the hazard function the scales were divided by the number of symptoms used to form the scale. The hazard represents the increase in risk associated with changing an average of one unit. The
hazard function for the 4-Item vs. Scale of Psychosis-Risk Symptoms Total scale in Cohort-1 p=0.005, Cohort-2 p=0.001.

1

Concordance
2
Index

1

Hazard function

value

Cohort-1

2-Item Subscale

Evaluation of discrimination in the derivation Cohort-1* and independent test Cohort-2*.
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